Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastatic × tusamitamab ravtansine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Non-small Cell Lung Cancer Metastatic 2 Neoplasms 2 Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) 1 Non-squamous Non-small Cell Lung Cancer 1 Breast Cancer Metastatic 1 Adenocarcinoma Gastric 1

Interventions

Fulvestrant 3 Letrozole 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 ribociclib 1 irinotecan sucrosofate 1 exemestane 1 abemaciclib 1 Zoledronic Acid 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Gemcitabine 1 Anastrozole 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04659603 2025-10-01

CARMEN-BT01

Sanofi

Phase 2 Terminated

50 enrolled 20 charts

BreastGastrointestinal

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡